Patents
Patents for C07C 239 - Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof (5,130)
10/2004
10/12/2004US6803388 Treating atherosclerosis and coronary artery diseases; stereoselective; chemical intermediates
10/06/2004EP1463717A2 Process for the synthesis of amine ethers from secondary amino oxides and uses
10/05/2004US6800097 For dyeing keratin fibers; hair dyes
09/2004
09/29/2004EP1100483B1 Glucocorticoid-selective anti-inflammatory agents
09/28/2004US6797731 Resorcinol derivatives
09/23/2004WO2004080492A1 Methods of radiofluorination of biologically active vectors
09/23/2004CA2518889A1 Methods of radiofluorination of biologically active vectors
09/16/2004DE3717389B4 Neue naphthylaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in der Human- und Veterinärmedizin und in der Kosmetik New naphthylaromatische compounds, processes for their preparation and their use in human and veterinary medicine and cosmetics
09/15/2004EP1456185A1 (1.2)-oxazin-3,5-diones
09/15/2004EP1456173A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/10/2004WO2004076053A2 Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds
09/10/2004WO2003079984A3 Substituted tetracycline compounds
09/10/2004CA2516465A1 Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds
09/09/2004US20040176425 Cycloalkyl containing anilide ligands for the thyroid receptor
09/09/2004US20040176398 for controlling unwanted microorganisms
09/08/2004EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
08/2004
08/26/2004WO2004072019A1 Method for producing hydroxylamine compound using platinum catalyst fixed on ion exchange resin
08/24/2004US6780998 Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/17/2004US6777440 For therapy of hiv infections; for therapy of aids or arc
08/12/2004WO2004066929A2 Cycloalkyl containing anilide ligands for the thyroid receptor
08/12/2004US20040157863 Triazolopyrimidines
08/04/2004EP1189875B1 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers
08/03/2004US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
08/03/2004US6770754 Functionalized polymeric or silica base material; do not include a pre-attached nucleoside, and therefore can be used universally for any na or rna synthesis; fast cleavage and dephosphorylation at relatively low temperatures
07/2004
07/29/2004WO2004062601A2 Antibacterial agents
07/29/2004US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex
07/29/2004CA2851462A1 Antibacterial agents
07/29/2004CA2512582A1 Antibacterial agents
07/27/2004CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
07/22/2004US20040142943 Antigrowth agents
07/15/2004WO2004058687A1 Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure
07/15/2004WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
07/15/2004WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
07/14/2004EP1282595B1 Novel phenyl-propargylether derivatives
07/14/2004CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents
07/07/2004EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
07/07/2004EP1434735A1 Stabilized hydroxylamine solutions
07/01/2004US20040127464 potent, selective and safe inhibitors of the Ca2+-activated potassium channel
06/2004
06/30/2004EP0832875B1 Highly water-soluble metalloproteinase inhibitor
06/29/2004CA2151817C Process for the preparation of hydroxylamine ethers and their salts and intermediates for this purpose
06/24/2004WO2004052836A1 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
06/24/2004CA2507669A1 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
06/22/2004US6753429 1,4-disubstituted benzenes as insecticides
06/17/2004WO2004018414A3 Antibacterial agents
06/16/2004CN1505632A Triazolopyrimidines
06/10/2004US20040110839 Compounds and compositions for delivering active agents
06/02/2004CN1500769A Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
05/2004
05/19/2004CN1496999A Solid phase synthesing method of aldehyde, ketonic, oxime amine and isohydroximic acid compound
05/13/2004US20040092685 Nitroxide free radical catalysts; transparent pressure sensitive adhesives; bonding strength
05/12/2004CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy
04/2004
04/29/2004WO2003045919A3 Process for the synthesis of amine ethers from secondary amino oxides and uses
04/28/2004CN1491937A 农药 Pesticide
04/27/2004US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases
04/22/2004WO2000061134A9 Antimicrobial agents
04/21/2004EP1154987B1 Phenylalaninol derivatives
04/21/2004CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors
04/20/2004US6723752 (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/15/2004US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents
04/14/2004EP1100772B1 Open chain alkoxyamine compounds and their use as polymerization regulators
04/07/2004EP1404695A2 Universal supports for oligonucleotide synthesis
04/06/2004US6716878 Antimicrobial agents
03/2004
03/30/2004CA2194502C 2-[1',2',4'-triazol-3'-yloxymethylene]anilides, their preparation and their use
03/25/2004WO2004024676A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
03/25/2004CA2498045A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
03/24/2004EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders
03/23/2004US6710208 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and α,β-unsaturated carboxylic acid and aldehyde compounds
03/17/2004EP1397362A2 Triazolopyrimidines having a fungicidal effect
03/04/2004WO2004018414A2 Antibacterial agents
03/04/2004US20040044048 Anticholesterol agents; cardiovascular disorders
03/03/2004EP1392695A2 Triazolopyrimidines
03/03/2004EP1392693A1 Triazolopyrimidines
03/03/2004EP1392648A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
03/03/2004EP1392637A2 Modulators of peroxisome proliferator activated receptors
03/03/2004EP1045839B1 Novel amines as pharmaceutical agents
03/03/2004CN1479717A Method for preparing N-substituted hydroxylamines and its salts
03/02/2004US6700007 Method for preparing alkoxyamines from nitroxides
03/02/2004US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration
02/2004
02/18/2004EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
02/17/2004US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia
02/11/2004EP0862575B1 Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
02/05/2004WO2004011410A1 Chemical compounds
02/05/2004WO2003074475A3 Substituted aryl ketones
02/05/2004CA2494668A1 Chemical compounds
02/03/2004US6686424 Preparation of functionalized alkoxyamine initiator and its use
01/2004
01/29/2004DE10232406A1 Verfahren zur Herstellung eines zeolithhaltigen Feststoffes A process for producing a zeolite solid
01/27/2004US6683211 Fungicides for crops
01/27/2004US6683113 (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/22/2004WO2004007462A1 Improved reagents for n-amination
01/22/2004WO2004007369A1 Method for producing a solid containing zeolites
01/22/2004WO2003049690A3 Hiv integrase inhibitors
01/22/2004US20040014591 Crystal structure; ultrafiltration; titanium silicates; catalyst
01/22/2004CA2492395A1 Production of a zeolite-containing solid
01/15/2004US20040009982 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
01/13/2004US6677341 (R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/08/2004WO2002044398A3 Universal supports for oligonucleotide synthesis
01/02/2004EP1375457A1 One-pot process for the preparation of functionalized alkoxyamines
12/2003
12/31/2003CN1132807C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
12/25/2003US20030236368 Preparation of functionalized alkoxyamine initiator and its use
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 52